Document is current

Any future updates will be listed below

Reply to the letter regarding “Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study”

Crossref DOI link: https://doi.org/10.1007/s12149-026-02216-x

Published Online: 2026-04-19

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark